All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
Unlike the Bel602 TCR, the T15 TCR possessed an Arg within its CDR3b loop, and it was of interest to compare how the T15 TCR and Bel602 TCR bound the DQ8.5-glia-g1 determinant. The T15 TCR engaged HLA-DQ8.5-glia-g1 in a similar docking position to the Bel602 TCR_x0004_. The salient features at the T15 TCR-HLA-DQ8.5-glia-g1 and Bel602 TCR-HLA-DQ8.5- glia-g1 interfaces were similar, including the role of the germline-encoded Arg37a from the TCR a chain as well as Leu37b and Tyr57b from the TCR b chain.
There are currently no customer reviews or questions for Human anti-Peptide GPQ T cell receptor (T15), pCDTCR1 (TCR-YC0915). Click the button below to contact us or submit your feedback about this product.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
For any technical issues or product/service related questions, please leave your information below. Our team will contact you soon.
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION